Last 12 months
Inside the activity.
9 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 1 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 5 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 2 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 04, 2022 Filed May 6, 2022 22:01 UTC |
GORDON ILENE SDirector
|
GrantRestricted Stock Units · Derivative | 1,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-006658 · doc4.xml · derivative · entry 2 GORDON ILENE S · CIK 0001049959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,245 Underlying: Common Stock · 1,245 shares Expires 2023-05-04 F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F3 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program. Read SEC document |
| May 04, 2022 Filed May 6, 2022 22:00 UTC |
Gold Christina ADirector
|
GrantRestricted Stock Units · Derivative | 1,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-006657 · doc4.xml · derivative · entry 2 Gold Christina A · CIK 0001051400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,245 Underlying: Common Stock · 1,245 shares Expires 2023-05-04 F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F3 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program. Read SEC document |
| May 04, 2022 Filed May 6, 2022 22:00 UTC |
Ferguson Roger W. Jr.Director
|
GrantRestricted Stock Units · Derivative | 1,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-006656 · doc4.xml · derivative · entry 1 Ferguson Roger W. Jr. · CIK 0001487637 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,245 Underlying: Common Stock · 1,245 shares Expires 2023-05-04 F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program. Read SEC document |
| May 04, 2022 Filed May 6, 2022 21:59 UTC |
DUCKER MICHAEL LDirector
|
GrantRestricted Stock Units · Derivative | 1,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-006655 · doc4.xml · derivative · entry 2 DUCKER MICHAEL L · CIK 0001188170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,245 Underlying: Common Stock · 1,245 shares Expires 2023-05-04 F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program. Read SEC document |
| May 04, 2022 Filed May 6, 2022 21:58 UTC |
DAVIDSON CAROL ANTHONYDirector
|
GrantRestricted Stock Units · Derivative | 1,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-006654 · doc4.xml · derivative · entry 2 DAVIDSON CAROL ANTHONY · CIK 0001277489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,245 Underlying: Common Stock · 1,245 shares Expires 2023-05-04 F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program. Read SEC document |
| May 04, 2022 Filed May 6, 2022 21:56 UTC |
Bruno Barry A.Director
|
GrantRestricted Stock Units · Derivative | 1,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-006653 · doc4.xml · derivative · entry 2 Bruno Barry A. · CIK 0001836877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,245 Underlying: Common Stock · 1,245 shares Expires 2023-05-04 F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F3 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program. Read SEC document |
| May 04, 2022 Filed May 6, 2022 21:56 UTC |
BREEN EDWARD DDirector
|
GrantRestricted Stock Units · Derivative | 1,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-006652 · doc4.xml · derivative · entry 2 BREEN EDWARD D · CIK 0001223619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,245 Underlying: Common Stock · 1,245 shares Expires 2023-05-04 F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F3 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program. Read SEC document |
| May 04, 2022 Filed May 6, 2022 21:55 UTC |
Boor Kathryn JeanDirector
|
GrantRestricted Stock Units · Derivative | 1,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-006651 · doc4.xml · derivative · entry 2 Boor Kathryn Jean · CIK 0001761826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,245 Underlying: Common Stock · 1,245 shares Expires 2023-05-04 F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program. Read SEC document |
| May 02, 2022 Filed May 3, 2022 23:59 UTC |
Fauchon de Villeplee ChristophePresident, Scent
|
SaleCommon Stock | 630 | $121.68 | $76,658.40 |
DisclosureSEC source: 0001225208-22-006398 · doc4.xml · nonDerivative · entry 1 Fauchon de Villeplee Christophe · CIK 0001881680 · President, Scent 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,809 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 13, 2021. Read SEC document |
| April 29, 2022 Filed May 2, 2022 21:08 UTC |
Anderson Robert G.Controller
|
GrantStock Equivalent Unit · Derivative | 11.497 | $121.30 | $1,394.59 |
DisclosureSEC source: 0001225208-22-006340 · doc4.xml · derivative · entry 2 Anderson Robert G. · CIK 0001692622 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,241.07 Underlying: Common Stock · 11.497 shares Expires not disclosed F1 · derivative.exercise_price: The Stock Equivalent Units ("Units") convert to Common Stock on a one-for-one basis. F2 · shares: Reflects Units under the Company's deferred compensation plan resulting from deferral of compensation and the 25% premium contributed by the Company on such Units. Units contributed by the Company are subject to vesting based on continued employment through December 31, 2023. F3 · derivative.exercise_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. F3 · derivative.expiration_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. Read SEC document |
| April 14, 2022 Filed Apr 18, 2022 21:20 UTC |
Anderson Robert G.Controller
|
GrantStock Equivalent Unit · Derivative | 11.118 | $125.43 | $1,394.53 |
DisclosureSEC source: 0001225208-22-005890 · doc4.xml · derivative · entry 2 Anderson Robert G. · CIK 0001692622 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,229.573 Underlying: Common Stock · 11.118 shares Expires not disclosed F1 · derivative.exercise_price: The Stock Equivalent Units ("Units") convert to Common Stock on a one-for-one basis. F2 · shares: Reflects Units under the Company's deferred compensation plan resulting from deferral of compensation and the 25% premium contributed by the Company on such Units. Units contributed by the Company are subject to vesting based on continued employment through December 31, 2023. F3 · derivative.exercise_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. F3 · derivative.expiration_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. Read SEC document |
| April 01, 2022 Filed Apr 6, 2022 01:58 UTC |
Fauchon de Villeplee ChristophePresident, Scent
|
Exercise / conversionStock Settled Appreciation Rights · Derivative | 285 | $0.00 Strike: $118.10 | $0.00 |
DisclosureSEC source: 0001225208-22-005637 · doc4.xml · derivative · entry 5 Fauchon de Villeplee Christophe · CIK 0001881680 · President, Scent 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 285 shares Expires 2022-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2022 Filed Apr 6, 2022 01:58 UTC |
Fauchon de Villeplee ChristophePresident, Scent
|
Exercise / conversionPurchased Restricted Stock Units · Derivative | 2,176 | $134.33 | $292,302.08 |
DisclosureSEC source: 0001225208-22-005637 · doc4.xml · derivative · entry 4 Fauchon de Villeplee Christophe · CIK 0001881680 · President, Scent 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,176 shares Expires 2022-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The PRSUs convert to Common Stock on a one-for-one basis. F2 · shares: Reflects vesting of Purchased Restricted Stock Units ("PRSUs") granted on May 1, 2019 pursuant to the Equity Choice Plan. Read SEC document |
| April 01, 2022 Filed Apr 6, 2022 01:58 UTC |
Fauchon de Villeplee ChristophePresident, Scent
|
Disposition to issuerCommon Stock | 256 | $134.33 | $34,388.48 |
DisclosureSEC source: 0001225208-22-005637 · doc4.xml · nonDerivative · entry 3 Fauchon de Villeplee Christophe · CIK 0001881680 · President, Scent 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,439 Read SEC document |
| April 01, 2022 Filed Apr 6, 2022 01:58 UTC |
Fauchon de Villeplee ChristophePresident, Scent
|
Exercise / conversionCommon Stock | 285 | $118.10 | $33,658.50 |
DisclosureSEC source: 0001225208-22-005637 · doc4.xml · nonDerivative · entry 2 Fauchon de Villeplee Christophe · CIK 0001881680 · President, Scent 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,695 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2022 Filed Apr 6, 2022 01:58 UTC |
Fauchon de Villeplee ChristophePresident, Scent
|
Exercise / conversionCommon Stock | 2,176 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-005637 · doc4.xml · nonDerivative · entry 1 Fauchon de Villeplee Christophe · CIK 0001881680 · President, Scent 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,410 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The PRSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| April 01, 2022 Filed Apr 6, 2022 01:36 UTC |
Anderson Robert G.Controller
|
Exercise / conversionPurchased Restricted Stock Units · Derivative | 1,741 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-005633 · doc4.xml · derivative · entry 3 Anderson Robert G. · CIK 0001692622 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,741 shares Expires 2022-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The PRSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting of Purchased Restricted Stock Units ("PRSUs") granted on May 1, 2019 pursuant to the Equity Choice Plan. Read SEC document |
| April 01, 2022 Filed Apr 6, 2022 01:36 UTC |
Anderson Robert G.Controller
|
Tax withholdingCommon Stock | 625 | $134.33 | $83,956.25 |
DisclosureSEC source: 0001225208-22-005633 · doc4.xml · nonDerivative · entry 2 Anderson Robert G. · CIK 0001692622 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,746.717 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of PRSUs. Read SEC document |
| April 01, 2022 Filed Apr 6, 2022 01:36 UTC |
Anderson Robert G.Controller
|
Exercise / conversionCommon Stock | 1,741 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-005633 · doc4.xml · nonDerivative · entry 1 Anderson Robert G. · CIK 0001692622 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,371.717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting of Purchased Restricted Stock Units ("PRSUs") granted on May 1, 2019 pursuant to the Equity Choice Plan. F2 · price: The PRSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| April 01, 2022 Filed Apr 6, 2022 01:38 UTC |
Herriott SimonPresident Health & Biosciences
|
GrantRestricted Stock Units · Derivative | 2,978 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-22-005635 · doc4.xml · derivative · entry 2 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,595 Underlying: Common Stock · 2,978 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units ("RSUs") convert into Common Stock on a one-for-one basis. F1 · price: Restricted Stock Units ("RSUs") convert into Common Stock on a one-for-one basis. F2 · derivative.exercise_date: The RSUs will vest in two equal tranches on each of April 1, 2023 and April 1, 2024, in each case subject to the reporting person's continued employment with the Company. F2 · derivative.expiration_date: The RSUs will vest in two equal tranches on each of April 1, 2023 and April 1, 2024, in each case subject to the reporting person's continued employment with the Company. Read SEC document |
| April 01, 2022 Filed Apr 6, 2022 01:36 UTC |
MIRZAYANTZ NICOLASPresident, Nourish
|
Exercise / conversionPurchased Restricted Stock Units · Derivative | 4,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-005634 · doc4.xml · derivative · entry 3 MIRZAYANTZ NICOLAS · CIK 0001211907 · President, Nourish 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,353 shares Expires 2022-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The PRSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting of Purchased Restricted Stock Units ("PRSUs") granted on May 1, 2019 pursuant to the Equity Choice Plan. Read SEC document |
| April 01, 2022 Filed Apr 6, 2022 01:36 UTC |
MIRZAYANTZ NICOLASPresident, Nourish
|
Tax withholdingCommon Stock | 2,042 | $134.33 | $274,301.86 |
DisclosureSEC source: 0001225208-22-005634 · doc4.xml · nonDerivative · entry 2 MIRZAYANTZ NICOLAS · CIK 0001211907 · President, Nourish 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,129 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of PRSUs. Read SEC document |
| April 01, 2022 Filed Apr 6, 2022 01:36 UTC |
MIRZAYANTZ NICOLASPresident, Nourish
|
Exercise / conversionCommon Stock | 4,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-005634 · doc4.xml · nonDerivative · entry 1 MIRZAYANTZ NICOLAS · CIK 0001211907 · President, Nourish 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting of Purchased Restricted Stock Units ("PRSUs") granted on May 1, 2019 pursuant to the Equity Choice Plan. F2 · price: The PRSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| April 01, 2022 Filed Apr 6, 2022 01:07 UTC |
Fortanet FranciscoEVP, Operations
|
Exercise / conversionPurchased Restricted Stock Units · Derivative | 5,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-005625 · doc4.xml · derivative · entry 4 Fortanet Francisco · CIK 0001351377 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,006 shares Expires 2022-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The PRSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting of Purchased Restricted Stock Units ("PRSUs") granted on May 1, 2019 pursuant to the Equity Choice Plan. Read SEC document |
| April 01, 2022 Filed Apr 6, 2022 01:07 UTC |
Fortanet FranciscoEVP, Operations
|
Tax withholdingCommon Stock | 1,912 | $134.33 | $256,838.96 |
DisclosureSEC source: 0001225208-22-005625 · doc4.xml · nonDerivative · entry 2 Fortanet Francisco · CIK 0001351377 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,237.438 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of PRSUs. Read SEC document |
| April 01, 2022 Filed Apr 6, 2022 01:07 UTC |
Fortanet FranciscoEVP, Operations
|
Exercise / conversionCommon Stock | 5,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-005625 · doc4.xml · nonDerivative · entry 1 Fortanet Francisco · CIK 0001351377 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,149.438 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting of Purchased Restricted Stock Units ("PRSUs") granted on May 1, 2019 pursuant to the Equity Choice Plan. F2 · price: The PRSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| March 30, 2022 Filed Apr 1, 2022 22:20 UTC |
Anderson Robert G.Controller
|
GrantStock Equivalent Unit · Derivative | 10.42 | $131.21 | $1,367.21 |
DisclosureSEC source: 0001225208-22-005321 · doc4.xml · derivative · entry 2 Anderson Robert G. · CIK 0001692622 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,179.621 Underlying: Common Stock · 10.42 shares Expires not disclosed F2 · derivative.exercise_price: The Stock Equivalent Units ("Units") convert to Common Stock on a one-for-one basis. F3 · shares: Reflects Units under the Company's deferred compensation plan resulting from deferral of compensation and the 25% premium contributed by the Company on such Units. Units contributed by the Company are subject to vesting based on continued employment through December 31, 2023. F4 · derivative.exercise_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. F4 · derivative.expiration_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 22:00 UTC |
Anderson Robert G.Controller
|
GrantStock Equivalent Unit · Derivative | 11.348 | $120.48 | $1,367.21 |
DisclosureSEC source: 0001225208-22-004872 · doc4.xml · derivative · entry 4 Anderson Robert G. · CIK 0001692622 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,169.201 Underlying: Common Stock · 11.348 shares Expires not disclosed F3 · derivative.exercise_price: The Stock Equivalent Units ("Units") convert to Common Stock on a one-for-one basis. F6 · shares: Reflects Units under the Company's deferred compensation plan resulting from deferral of compensation and the 25% premium contributed by the Company on such Units. Units contributed by the Company are subject to vesting based on continued employment through December 31, 2023. F5 · derivative.exercise_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. F5 · derivative.expiration_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 22:00 UTC |
Anderson Robert G.Controller
|
GrantStock Equivalent Unit · Derivative | 309.115 | $120.48 | $37,242.18 |
DisclosureSEC source: 0001225208-22-004872 · doc4.xml · derivative · entry 3 Anderson Robert G. · CIK 0001692622 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,157.853 Underlying: Common Stock · 309.115 shares Expires not disclosed F3 · derivative.exercise_price: The Stock Equivalent Units ("Units") convert to Common Stock on a one-for-one basis. F4 · shares: Reflects Units received upon deferral of a portion of the reporting person's annual incentive plan into the Company's stock fund and the premium contributed by the Company on such Units. The Company premium, or 61.823 of the acquired Units, are subject to vesting based on employment through December 31, 2023. F5 · derivative.exercise_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. F5 · derivative.expiration_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 22:00 UTC |
Anderson Robert G.Controller
|
Tax withholdingCommon Stock | 288 | $120.48 | $34,698.24 |
DisclosureSEC source: 0001225208-22-004872 · doc4.xml · nonDerivative · entry 2 Anderson Robert G. · CIK 0001692622 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,612.717 F2 · shares: Shares withheld to satisfy tax withholding obligations in connection with the receipt of shares under the Integration Award. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 22:00 UTC |
Anderson Robert G.Controller
|
GrantCommon Stock | 662 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-004872 · doc4.xml · nonDerivative · entry 1 Anderson Robert G. · CIK 0001692622 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,900.717 F1 · shares: These shares represent the 70% portion of the reporting person's payout under the Integration Award granted on January 2, 2019 (the "Integration Award"), settled in shares of the issuer's Common Stock. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:07 UTC |
Bruno Barry A.Director
|
GrantRestricted Stock Units · Derivative | 289 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003890 · doc4.xml · derivative · entry 1 Bruno Barry A. · CIK 0001836877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289 Underlying: Common Stock · 289 shares Expires 2022-05-05 F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:19 UTC |
Clyburn FrankChief Executive Officer
|
GrantStock Settled Appreciation Rights · Derivative | 29,613 | $0.00 Strike: $128.41 | $0.00 |
DisclosureSEC source: 0001225208-22-004197 · doc4.xml · derivative · entry 3 Clyburn Frank · CIK 0001763963 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,613 Underlying: Common Stock · 29,613 shares Expires 2029-03-01 F4 · shares: The Stock Settled Appreciation Rights will vest in three equal tranches on each of March 1, 2023, March 1, 2024, and March 1, 2025, in each case subject to the reporting person's continued employment with the Company. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:19 UTC |
Clyburn FrankChief Executive Officer
|
GrantRestricted Stock Units · Derivative | 23,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-004197 · doc4.xml · derivative · entry 2 Clyburn Frank · CIK 0001763963 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,363 Underlying: Common Stock · 23,363 shares Expires 2025-03-01 F3 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:19 UTC |
Clyburn FrankChief Executive Officer
|
GrantRestricted Deferred Stock Units · Derivative | 6,619 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-004197 · doc4.xml · derivative · entry 1 Clyburn Frank · CIK 0001763963 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,619 Underlying: Common Stock · 6,619 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Restricted Stock Units ("DSUs") convert to Common Stock on a one-for-one basis. F2 · derivative.exercise_date: The DSUs will vest in five equal tranches on each of March 1, 2023, March 1, 2024, March 1, 2025, March 1, 2026, and March 1, 2027, in each case subject to the reporting person's continued employment with the Company. The DSUs are payable in Common Stock upon termination of employment. F2 · derivative.expiration_date: The DSUs will vest in five equal tranches on each of March 1, 2023, March 1, 2024, March 1, 2025, March 1, 2026, and March 1, 2027, in each case subject to the reporting person's continued employment with the Company. The DSUs are payable in Common Stock upon termination of employment. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 22:07 UTC |
Anderson Robert G.Controller
|
GrantStock Equivalent Unit · Derivative | 10.28 | $133.00 | $1,367.24 |
DisclosureSEC source: 0001225208-22-003891 · doc4.xml · derivative · entry 2 Anderson Robert G. · CIK 0001692622 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,848.738 Underlying: Common Stock · 10.28 shares Expires not disclosed F1 · derivative.exercise_price: The Stock Equivalent Units ("Units") convert to Common Stock on a one-for-one basis. F2 · shares: Reflects Units under the Company's deferred compensation plan resulting from deferral of compensation and the 25% premium contributed by the Company on such Units. Units contributed by the Company are subject to vesting based on continued employment through December 31, 2023. F3 · derivative.exercise_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. F3 · derivative.expiration_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. F4 · balance_after: The amount reported has been reduced by an aggregate of 4.027 shares that were reversed from the reporting person's deferred compensation plan account due to an error in the contribution calculation by the deferred compensation plan administrator. Read SEC document |
| February 19, 2022 Filed Feb 23, 2022 21:05 UTC |
Herriott SimonPresident Health & Biosciences
|
Exercise / conversionRestricted Stock Units · Derivative | 616 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003050 · doc4.xml · derivative · entry 3 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 617 Underlying: Common Stock · 616 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on February 19, 2022. F4 · derivative.expiration_date: The RSUs vested on February 19, 2022. Read SEC document |
| February 19, 2022 Filed Feb 23, 2022 21:05 UTC |
Herriott SimonPresident Health & Biosciences
|
Tax withholdingCommon Stock | 155 | $135.03 | $20,929.65 |
DisclosureSEC source: 0001225208-22-003050 · doc4.xml · nonDerivative · entry 2 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,823.665 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| February 19, 2022 Filed Feb 23, 2022 21:05 UTC |
Herriott SimonPresident Health & Biosciences
|
Exercise / conversionCommon Stock | 616 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003050 · doc4.xml · nonDerivative · entry 1 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,978.665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 19, 2022 Filed Feb 23, 2022 21:05 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 708 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003049 · doc4.xml · derivative · entry 3 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,790 Underlying: Common Stock · 708 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on February 19, 2022. F4 · derivative.expiration_date: The RSUs vested on February 19, 2022. Read SEC document |
| February 19, 2022 Filed Feb 23, 2022 21:05 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Tax withholdingCommon Stock | 273 | $135.03 | $36,863.19 |
DisclosureSEC source: 0001225208-22-003049 · doc4.xml · nonDerivative · entry 2 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,338 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| February 19, 2022 Filed Feb 23, 2022 21:05 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Exercise / conversionCommon Stock | 708 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003049 · doc4.xml · nonDerivative · entry 1 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,611 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 19, 2022 Filed Feb 23, 2022 21:02 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Exercise / conversionRestricted Stock Units · Derivative | 585 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003048 · doc4.xml · derivative · entry 3 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,266 Underlying: Common Stock · 585 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on February 19, 2022. F4 · derivative.expiration_date: The RSUs vested on February 19, 2022. Read SEC document |
| February 19, 2022 Filed Feb 23, 2022 21:02 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Tax withholdingCommon Stock | 188 | $135.03 | $25,385.64 |
DisclosureSEC source: 0001225208-22-003048 · doc4.xml · nonDerivative · entry 2 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,815 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| February 19, 2022 Filed Feb 23, 2022 21:02 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Exercise / conversionCommon Stock | 585 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003048 · doc4.xml · nonDerivative · entry 1 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,003 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:27 UTC |
Anderson Robert G.Controller
|
GrantStock Equivalent Unit · Derivative | 10.108 | $135.26 | $1,367.21 |
DisclosureSEC source: 0001225208-22-002455 · doc4.xml · derivative · entry 2 Anderson Robert G. · CIK 0001692622 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,839.081 Underlying: Common Stock · 10.108 shares Expires not disclosed F1 · derivative.exercise_price: The Stock Equivalent Units ("Units") convert to Common Stock on a one-for-one basis. F2 · shares: Reflects Units under the Company's deferred compensation plan resulting from deferral of compensation and the 25% premium contributed by the Company on such Units. Units contributed by the Company are subject to vesting based on continued employment through December 31, 2023. F3 · derivative.exercise_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. F3 · derivative.expiration_date: The Units are payable in Common Stock upon earlier of termination of employment or January 1 following retirement. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 23:44 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Exercise / conversionRestricted Stock Units · Derivative | 366 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002342 · doc4.xml · derivative · entry 3 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,851 Underlying: Common Stock · 366 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 14, 2019. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on February 14, 2022. F4 · derivative.expiration_date: The RSUs vested on February 14, 2022. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 23:44 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Tax withholdingCommon Stock | 120 | $132.10 | $15,852.00 |
DisclosureSEC source: 0001225208-22-002342 · doc4.xml · nonDerivative · entry 2 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,418 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 23:44 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Exercise / conversionCommon Stock | 366 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002342 · doc4.xml · nonDerivative · entry 1 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 14, 2019. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 23:37 UTC |
Herriott SimonPresident Health & Biosciences
|
Exercise / conversionRestricted Stock Units · Derivative | 525 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002341 · doc4.xml · derivative · entry 3 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,233 Underlying: Common Stock · 525 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 14, 2019. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on February 14, 2022. F4 · derivative.expiration_date: The RSUs vested on February 14, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.